Kristin Thompson

Kristin Thompson is a Vice President at Guardian Therapeutics Inc. Kristin has held various positions in reputable companies such as Guardian Therapeutics, Homology Medicines, and PhaseRx. Kristin has a strong background in molecular biology and extensive experience in project management, alliance management, and technology platform development. Kristin holds a PhD in Molecular Biology from The University of Texas at Austin.